MedPath

HK inno.N Corporation

๐Ÿ‡ฐ๐Ÿ‡ทSouth Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301

Phase 3
Completed
Conditions
Parenteral Nutrition
Interventions
Drug: IN-C006 Peri inj.
First Posted Date
2022-04-20
Last Posted Date
2023-09-28
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
59
Registration Number
NCT05337228
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Seoul National University Hospital, Seoul, Korea, Republic of

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

Phase 3
Completed
Conditions
Parenteral Nutrition
Interventions
Drug: IN-C006 inj.
First Posted Date
2022-03-28
Last Posted Date
2023-09-28
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
60
Registration Number
NCT05299099
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Seoul National University Hospital, Seoul, Korea, Republic of

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease

Phase 4
Completed
Conditions
Erosive Reflux Disease
Interventions
First Posted Date
2022-03-04
Last Posted Date
2022-07-29
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
218
Registration Number
NCT05267743
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Wonkwang University Hospital, Iksan, Muwang-ro 895, Korea, Republic of

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

Phase 1
Conditions
Hypertension
Interventions
Drug: Telminone 80 mg
First Posted Date
2022-02-03
Last Posted Date
2022-03-02
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
46
Registration Number
NCT05223101
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of

Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)

Phase 1
Conditions
COVID-19
First Posted Date
2021-11-09
Last Posted Date
2021-11-09
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
40
Registration Number
NCT05113849
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Chungbuk National University Hospital, Chungju, Korea, Republic of

๐Ÿ‡ฐ๐Ÿ‡ท

Jeonbuk National University Hospital, Jeonju, Korea, Republic of

๐Ÿ‡ฐ๐Ÿ‡ท

Seoul National University Hospital, Seoul, Korea, Republic of

A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Hypertension
Interventions
Drug: Telmione plus 80/12.5mg
First Posted Date
2021-09-10
Last Posted Date
2022-02-16
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
46
Registration Number
NCT05040880
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of

A Study to Investigate the Effect of Food on the Pharmacokinetics of IN-A002 Capsule in Healthy Male Subjects

Phase 1
Conditions
Healthy
Interventions
Drug: IN-A002(IN-115314) capsule
First Posted Date
2021-08-25
Last Posted Date
2021-08-25
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
12
Registration Number
NCT05019755
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Seoul National University Hospital, Dept. of Clinical Pharmacology, Seoul, Korea, Republic of

Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: IN-C005 X mg
Drug: IN-C005 Y mg
Drug: IN-C005 Z mg
First Posted Date
2021-08-13
Last Posted Date
2022-05-16
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
20
Registration Number
NCT05005065
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Seoul National University Hospital, Seoul, Jongro Gu, Korea, Republic of

๐Ÿ‡ฐ๐Ÿ‡ท

Seoul National University Hopsital, Seoul, Korea, Republic of

Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs

Phase 3
Recruiting
Conditions
Preventive Peptic Ulcer
Interventions
First Posted Date
2021-04-12
Last Posted Date
2023-07-14
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
390
Registration Number
NCT04840550
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Samsung Medical Center, Seoul, Korea, Republic of

๐Ÿ‡ฐ๐Ÿ‡ท

The catholic univ. of Korea Eunpyeong ST. Mari's hospital, Seoul, Korea, Republic of

Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2020-12-04
Last Posted Date
2021-01-29
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
6
Registration Number
NCT04654065
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Chonbuk National University Hospital, Jeonju, Korea, Republic of

ยฉ Copyright 2025. All Rights Reserved by MedPath